AGMB,UXIN Stock Price and Quote

Peers: INCY KYMR BMRN CRNX RYTM VKTX KRYS AXSM MDGL NBIX

Index	-
Market Cap	433.40M
Enterprise Value	146.61M
Income	-
Sales	-
Book/sh	6.16
Cash/sh	5.85
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	62
IPO	Feb 06, 2026

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	1.43
P/C	1.50
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	12.88
Current Ratio	12.88
Debt/Eq	0.00
LT Debt/Eq	0.00
Option/Short	No / Yes

EPS (ttm)	-
EPS next Y	-2.09
EPS next Q	-0.37
EPS this Y	98.89%
EPS next Y	-17.49%
EPS next 5Y	75.99%
EPS past 3/5Y	-102.05% -
Sales past 3/5Y	- -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	-
Sales Q/Q	-
Earnings	Aug 06 AMC
EPS/Sales Surpr.	-177.84% -

Insider Own	25.98%
Insider Trans	0.24%
Inst Own	26.72%
Inst Trans	0.09%
ROA	-
ROE	-
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-19.09%
SMA50	-30.61%
SMA200	-29.37%
Trades

Shs Outstand	48.74M
Shs Float	36.45M
Short Float	2.38%
Short Ratio	6.42
Short Interest	0.87M
52W High	17.82 -50.62%
52W Low	7.97 10.41%
Volatility	14.57% 10.41%
ATR (14)	1.07
RSI (14)	31.17
Beta	-
Rel Volume	0.00
Avg Volume	135.14K
Volume	0

Perf Week	-20.72%
Perf Month	-40.98%
Perf Quarter	-32.46%
Perf Half Y	-10.66%
Perf YTD	-40.14%
Perf Year	-
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	1.00
Target Price	37.73
Prev Close	8.80
Price	8.80
Change %	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-25-26	Initiated	Piper Sandler	Overweight	$60
Aug-19-26	Initiated	Cantor Fitzgerald	Overweight
Jul-23-26	Initiated	B. Riley Securities	Buy	$34
Jun-22-26	Initiated	H.C. Wainwright	Buy	$35
Mar-03-26	Initiated	Morgan Stanley	Overweight	$28
Mar-03-26	Initiated	Leerink Partners	Outperform	$36
Mar-03-26	Initiated	JP Morgan	Overweight	$32

Oct-01-26 09:27AM	Agomab stock jumps on positive trial data (Investing.com) -22.07%
06:30AM	Agomab Reports Positive Topline Data from STENOVA Open-Label Extension Study of Ontunisertib in Fibrostenosing Crohn's Disease (GlobeNewswire)
Sep-14-26 04:05PM	Agomab Announces Positive Phase 1 Results for AGMB-447 in Patients with Idiopathic Pulmonary Fibrosis and Design of Phase 2 INSPIRIA Study (GlobeNewswire) -5.97%
Sep-11-26 04:05PM	Agomab Announces Appointments of Marino Garcia and Dr. Naimish Patel to Board of Directors (GlobeNewswire) -6.31%
Sep-03-26 04:05PM	Agomab to Participate in Upcoming Investor Conferences (GlobeNewswire) +8.57% +6.41%
04:07PM	Loading…
Aug-10-26 04:07PM	Agomab Announces Proposed Appointments of Marino Garcia and Dr. Naimish Patel to Board of Directors (GlobeNewswire)
Aug-06-26 04:01PM	Agomab Reports Half Year 2026 Financial Results and Confirms 2026 Outlook (GlobeNewswire) -5.73% +7.41%
Jun-23-26 04:05PM	Agomab Announces Design of NOV-ERA Phase 2b Study with Ontunisertib in Fibrostenosing Crohn's Disease (GlobeNewswire) +6.20%
May-27-26 05:00AM	Agomab Announces Results of Annual General Meeting (GlobeNewswire) +5.61%
May-14-26 07:30AM	Agomab to Participate in Upcoming Conferences (GlobeNewswire)
Apr-23-26 06:14PM	Agomab Reports Full Year 2025 Financial Results and Confirms 2026 Outlook (GlobeNewswire)
Mar-26-26 07:00AM	Agomab Receives U.S. Patent for AGMB-447, its Inhaled Lung-restricted Small Molecule Inhibitor of ALK5 in Development for the Treatment of Idiopathic Pulmonary Fibrosis (GlobeNewswire) -7.70%
Feb-09-26 04:05PM	Agomab Announces Closing of Initial Public Offering (GlobeNewswire) +6.55%
Feb-07-26 10:55AM	Agomab indicated to open at $15.50, IPO priced at $16 (TipRanks)
Feb-05-26 07:24PM	Agomab Announces Pricing of Initial Public Offering (GlobeNewswire)

AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases. Its mission is to develop disease-modifying therapeutics that aim to resolve fibrosis and restore organ function, enabling patients with these disorders to live fuller and healthier lives. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium.

Ph.D.Dr. Tim Knotnerus MSc

FounderMr. Paolo Michieli Ph.D.

Chief Financial OfficerMr. Pierre Kemula B.Sc.

Vice President of Investor RelationsSofie Van Gijsel

General CounselMs. Ellen Lefever

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Epstein David R	Director	Oct 06 '26	Buy	8.70	5,000	43,500	10,000	Oct 07 08:57 AM
Epstein David R	Director	Oct 05 '26	Buy	8.57	5,000	42,850	5,000	Oct 07 08:57 AM
Kemula Pierre Thadee Victor	Chief Financial Officer	Oct 06 '26	Buy	8.59	10,000	85,940	10,000	Oct 07 08:47 AM
Knotnerus Tim Jasper	Chief Executive Officer	Oct 05 '26	Buy	8.48	6,000	50,880	16,823	Oct 07 08:06 AM
Knotnerus Tim Jasper	Chief Executive Officer	Oct 06 '26	Buy	8.70	5,000	43,500	21,823	Oct 07 08:06 AM

Peers: ACVA CARG CVNA KMX CARS EBAY AAP AZO GPC ORLY

| Held by: GXC

Index	-
Market Cap	266.01M
Enterprise Value	585.20M
Income	-62.26M
Sales	615.97M
Book/sh	-0.25
Cash/sh	0.06
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	2437
IPO	Jun 27, 2018

P/E	-
Forward P/E	-
PEG	-
P/S	0.43
P/B	-
P/C	21.84
P/FCF	-
EV/EBITDA	-
EV/Sales	0.95
Quick Ratio	0.27
Current Ratio	0.74
Debt/Eq	-
LT Debt/Eq	-
Option/Short	No / Yes

EPS (ttm)	-0.28
EPS next Y	-0.00
EPS next Q	-
EPS this Y	-
EPS next Y	28.56%
EPS next 5Y	-
EPS past 3/5Y	81.48% 59.50%
Sales past 3/5Y	14.47% 35.98%
EPS Y/Y TTM	-42.04%
Sales Y/Y TTM	97.00%
EPS Q/Q	-145.19%
Sales Q/Q	85.83%
Earnings	Sep 24 BMO
EPS/Sales Surpr.	- -

Insider Own	0.05%
Insider Trans	-
Inst Own	1.97%
Inst Trans	14.98%
ROA	-20.01%
ROE	-
ROIC	-42.76%
Gross Margin	4.90%
Oper. Margin	-8.09%
Profit Margin	-10.11%
SMA20	0.71%
SMA50	1.26%
SMA200	-50.24%
Trades

Shs Outstand	219.84M
Shs Float	219.73M
Short Float	0.24%
Short Ratio	1.17
Short Interest	0.52M
52W High	4.18 -71.05%
52W Low	0.90 35.00%
Volatility	8.11% 8.03%
ATR (14)	0.10
RSI (14)	48.74
Beta	0.82
Rel Volume	0.00
Avg Volume	449.37K
Volume	0

Perf Week	-8.33%
Perf Month	1.68%
Perf Quarter	-31.64%
Perf Half Y	-59.26%
Perf YTD	-64.09%
Perf Year	-63.99%
Perf 3Y	-92.04%
Perf 5Y	-99.55%
Perf 10Y	-
Recom	1.00
Target Price	2.60
Prev Close	1.21
Price	1.21
Change %	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-23-19	Downgrade	JP Morgan	Overweight → Neutral
Mar-12-19	Initiated	Credit Suisse	Outperform	$7.70
Jan-10-19	Upgrade	JP Morgan	Neutral → Overweight
Dec-21-18	Downgrade	Goldman	Buy → Neutral
Aug-16-18	Initiated	Goldman	Buy

Sep-24-26 03:00PM	Uxin Ltd (UXIN) Q2 2026 Earnings Call Highlights: Surging Retail Volume and Margin Recovery Ahead (GuruFocus.com) +19.27%
09:55AM	Uxin Shares Rise as Q2 Revenue Increases 74.9% and Company Issues Q3 Guidance (InvestorsHub)
04:20AM	Uxin Reports Unaudited Financial Results for the Quarter Ended June 30, 2026 (PR Newswire)
Sep-16-26 06:00AM	Uxin to Report Second Quarter 2026 Financial Results on September 24, 2026 (PR Newswire)
Jul-20-26 04:00AM	Uxin Announces Launch of New Used Car Superstore Project in Shaoxing (PR Newswire) -9.50%
05:00AM	Loading…
Jul-01-26 05:00AM	Uxin Announces Adoption of Rule 10b5-1 Purchase Plan by Entity Controlled by Chairman and CEO (PR Newswire) +25.16%
Jun-29-26 06:00AM	Uxin Announces Closing of US$15 Million Investment from Parties Designated by NIO Capital under Previously Announced Share Subscription Agreements (PR Newswire)
Jun-25-26 07:00AM	Uxin Highlights Operational Strength and Long-Term Growth Strategy at 2026 Investor Day (PR Newswire)
Jun-23-26 06:00AM	Uxin Addresses Investors' Most Frequently Asked Questions on Industry Outlook and Growth Strategy (PR Newswire) -5.26%
Jun-18-26 06:45AM	Uxin Announces Management Share Purchase Plan (PR Newswire) +5.49%
Jun-16-26 03:00PM	Uxin Ltd (UXIN) Q1 2026 Earnings Call Highlights: Surging Retail Sales Amid Market Challenges (GuruFocus.com) -10.38%
03:00AM	Uxin Reports Unaudited Financial Results for the Quarter Ended March 31, 2026 (PR Newswire)
Jun-09-26 06:30AM	Uxin to Report First Quarter 2026 Financial Results on June 16, 2026 (PR Newswire)
Jun-02-26 04:15AM	Uxin Enters into Joint Venture Agreement with Shijiazhuang State-Owned Enterprise (PR Newswire)
May-21-26 03:00AM	Uxin Announces Launch of New Used Car Superstore Project in Chongqing (PR Newswire) -7.56%
03:00AM	Loading…
Apr-11-26 03:00AM	Uxin Ltd (UXIN) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Margin Pressures (GuruFocus.com)
Apr-10-26 02:00AM	Uxin Reports Unaudited Financial Results for the Quarter and Full Year Ended December 31, 2025 (PR Newswire)
Apr-06-26 05:00AM	Uxin to Report Fourth Quarter and Full Year 2025 Financial Results on April 10, 2026 (PR Newswire)
Mar-31-26 02:30AM	Uxin Announces Official Opening of Its Tianjin Used Car Superstore (PR Newswire)
Mar-03-26 05:00AM	Uxin Announces Strategic Partnership with State-Owned Enterprises in Jiangyin (PR Newswire)
Dec-26-25 06:00AM	Uxin Announces Entry into Share Subscription Agreements with NIO Capital and Prestige Shine Group Limited (PR Newswire) +6.70%
Dec-18-25 02:00PM	Uxin Ltd (UXIN) Q3 2025 Earnings Call Highlights: Record Growth in Retail Transactions and Revenue (GuruFocus.com) +10.95%
02:00AM	Uxin Reports Unaudited Financial Results for the Quarter Ended September 30, 2025 and Announces Entry into Definitive Agreement for Financing (PR Newswire)
Dec-16-25 09:30PM	Uxin Announces Official Opening of Its Jinan Used Car Superstore (PR Newswire) +6.39%
Dec-12-25 03:00AM	Uxin to Report Third Quarter 2025 Financial Results on December 18, 2025 (PR Newswire)
Nov-12-25 04:30AM	Uxin Announces Strategic Partnership with Tianjin Authorities to Develop Tianjin Used Car Superstore (PR Newswire)
Nov-11-25 06:00AM	Uxin Announces Strategic Partnership with Yinchuan Authorities to Develop Yinchuan Used Car Superstore (PR Newswire)
Oct-31-25 04:40AM	Uxin Announces Strategic Partnership with Guangzhou Authorities to Build Guangzhou Used Car Superstore (PR Newswire)
Sep-29-25 03:00PM	Uxin Ltd (UXIN) Q2 2025 Earnings Call Highlights: Robust Retail Growth Amidst Expansion Challenges (GuruFocus.com)
03:00AM	Uxin Reports Unaudited Financial Results for the Quarter Ended June 30, 2025 (PR Newswire)
02:00AM	Loading…
Sep-26-25 02:00AM	Uxin Announces Grand Opening of Zhengzhou Used Car Superstore (PR Newswire)
Sep-23-25 06:00AM	Uxin to Report Second Quarter 2025 Financial Results on September 29, 2025 (PR Newswire)
Sep-12-25 04:00AM	Uxin to Present at Sidoti September Virtual Investor Conference September 17-18, 2025 (PR Newswire)
Sep-11-25 04:00AM	Uxin to Present at Investor Summit Virtual on September 16, 2025 (PR Newswire) +9.39%
Sep-09-25 01:20PM	John Lin, CFO of Uxin Limited, to Present at Investor Summit Virtual on September 16, 2025 (ACCESSWIRE)
Jul-16-25 07:00AM	Presenting on Emerging Growth Conference 84 Day 2 on July 17; Register to live stream (GlobeNewswire)
Jul-11-25 08:00AM	Uxin to Present at the Emerging Growth Conference on July 17, 2025 (PR Newswire) +33.85%
Jun-13-25 07:45AM	Why Uxin Stock Was Crushing It This Week (Motley Fool) -7.02%
Jun-12-25 04:50AM	Uxin Reports Unaudited Financial Results for the Quarter Ended March 31, 2025 (PR Newswire) -8.49%
Jun-06-25 07:50AM	Uxin to Report First Quarter 2025 Financial Results on June 12, 2025 (PR Newswire)
May-01-25 03:07AM	Uxin Ltd (UXIN) Q4 2024 Earnings Call Highlights: Record Growth and Positive EBITDA Mark a ... (GuruFocus.com) +10.45%
Apr-30-25 11:34PM	Q4 2024 Uxin Ltd Transition Period Ending December 31, 2024 Earnings Call (Thomson Reuters StreetEvents) +9.07%
02:49PM	Uxin Limited (UXIN) Q4 2024 Earnings Call Transcript (Seeking Alpha)
03:32AM	Uxin Full Year 2024 Annual Letter to Shareholders (PR Newswire)
03:30AM	Uxin Reports Unaudited Financial Results for the Quarter and Full Year Ended December 31, 2024 (PR Newswire)
Apr-23-25 05:00AM	Uxin to Report Fourth Quarter and Full Year 2024 Financial Results on April 30, 2025 (PR Newswire)
Mar-26-25 11:22PM	Uxin: Why Its Future Is Still Up In The Air (SeekingAlpha)
Mar-05-25 04:00AM	Uxin Announces Entry into Definitive Agreements for Financing (PR Newswire)
Dec-03-24 08:38AM	Uxin Announces Strategic Partnership with CATL's Subsidiary to Develop Battery Swapping Ecosystem for Used Cars (PR Newswire) +21.09%
Nov-26-24 06:50AM	Uxins Impressive Growth in Q3 2024 Financials (TipRanks) -16.14%
Nov-25-24 03:30AM	Uxin Reports Unaudited Financial Results for the Quarter Ended September 30, 2024 (PR Newswire) -19.49%
03:29AM	Uxin Announces Change of Fiscal Year End (PR Newswire)
Nov-18-24 04:00AM	Uxin to Report Second Quarter Fiscal Year 2025 Financial Results on November 25, 2024 (PR Newswire)
Oct-16-24 07:40AM	Uxin Announces Strategic Partnership with Wuhan City Economic & Technological Development Zone (PR Newswire) +15.12%
Sep-24-24 03:00AM	Uxin Ltd (UXIN) Q1 2025 Earnings Call Transcript Highlights: Strong Retail Sales Growth and ... (GuruFocus.com)
Sep-23-24 10:04PM	Q1 2025 Uxin Ltd Earnings Call (Thomson Reuters StreetEvents) +56.47%
02:26PM	Why Uxin Stock Was Skyrocketing Today (Motley Fool)
04:57AM	Uxin Posts Narrower Loss From Operations In Q1; Revenues Up 38.8% (RTT News)
04:34AM	Uxin Reports Unaudited First Quarter of Fiscal Year 2025 Financial Results (PR Newswire)
Sep-18-24 05:00AM	Uxin to Report First Quarter Fiscal Year 2025 Financial Results on September 23, 2024 (PR Newswire)
Sep-13-24 05:00AM	Uxin Announces Entry into a Memorandum of Understanding for a Proposed Investment (PR Newswire)
Jul-31-24 04:30AM	Uxin Reports Unaudited Fourth Quarter and Fiscal Year 2024 Financial Results (PR Newswire) -6.43%
Jul-25-24 07:00AM	Uxin to Report Fourth Quarter and Fiscal Year 2024 Financial Results on July 31, 2024 (PR Newswire)
Jul-08-24 05:02AM	Uxin Announces Strategic Partnership with Zhengzhou Airport Industry (PR Newswire)
May-01-24 08:52AM	Uxin Limited (NASDAQ:UXIN) Q3 2024 Earnings Call Transcript (Insider Monkey) +5.41%
Apr-25-24 01:54PM	UXIN Stock Earnings: Uxin Reported Results for Q3 2024 (InvestorPlace)
04:33AM	Uxin Reports Unaudited Third Quarter of Fiscal Year 2024 Financial Results (PR Newswire)
Apr-19-24 06:00AM	Uxin to Report Third Quarter Fiscal Year 2024 Financial Results on April 25, 2024 (PR Newswire)
Mar-18-24 05:00AM	Uxin Announces Entry into a Term Sheet for Financing (PR Newswire)
Mar-01-24 06:00AM	Uxin Announces Results of Extraordinary General Meeting (PR Newswire)
Jan-30-24 05:00AM	Uxin to Hold an Extraordinary General Meeting on March 1, 2024 (PR Newswire)
Dec-06-23 03:00AM	Uxin Limited Announces Successful Validation of Superstore Business Model, Significant Reduction in Losses, and Target of Achieving Overall Profitability by 2024 (PR Newswire)
Dec-01-23 08:14AM	Uxin Limited (NASDAQ:UXIN) Q2 2024 Earnings Call Transcript (Insider Monkey) -7.34%
Nov-29-23 12:55AM	Q1 2024 Uxin Ltd Earnings Call (Thomson Reuters StreetEvents) -7.42%
Nov-28-23 03:40AM	Uxin Limited Announces Successful Validation of Superstore Business Model, Significant Reduction in Losses, and Target of Achieving Overall Profitability by 2024 (PR Newswire) -7.30%
03:38AM	Uxin Reports Unaudited Second Quarter of Fiscal Year 2024 Financial Results (PR Newswire)
03:35AM	Uxin Reports Unaudited First Quarter of Fiscal Year 2024 Financial Results (PR Newswire)
Nov-22-23 05:00AM	Uxin to Report First and Second Quarter Fiscal Year 2024 Financial Results on November 28, 2023 (PR Newswire)
Sep-20-23 08:17AM	Uxin Announces RMB1.5 Billion Equity Investment in Its Hefei Subsidiary (PR Newswire)
Aug-17-23 01:10PM	UXIN: Uxin reports strong year over year growth in vehicle units sold. (Zacks)
10:52AM	Uxin Limited (NASDAQ:UXIN) Q4 2023 Earnings Call Transcript (Insider Monkey)
Aug-14-23 10:45PM	Q4 2023 Uxin Ltd Earnings Call (Thomson Reuters StreetEvents) +5.76%
06:00AM	Uxin Reports Unaudited Fourth Quarter and Fiscal Year 2023 Financial Results (PR Newswire)
Aug-08-23 07:00AM	Uxin to Report Fourth Quarter and Fiscal Year 2023 Financial Results on August 14, 2023 (PR Newswire)
May-02-23 09:25AM	UXIN: Update on the companys 3rd fiscal quarter results which were broadly in line with expectations. Strong unit sales growth occurred despite difficult market conditions. (Zacks Small Cap Research)
Apr-17-23 08:07AM	Market Cool On Uxin Limited's (NASDAQ:UXIN) Revenues Pushing Shares 49% Lower (Simply Wall St.) +6.22%
Apr-11-23 10:27PM	Q3 2023 Uxin Ltd Earnings Call (Thomson Reuters StreetEvents) -22.54% -12.70%
04:20AM	Uxin Reports Unaudited Third Quarter of Fiscal Year 2023 Financial Results (GlobeNewswire)
Apr-06-23 07:49AM	Uxin Limited (NASDAQ:UXIN) most popular amongst individual investors who own 34% of the shares, institutions hold 21% (Simply Wall St.)
Apr-05-23 03:30AM	Uxin Provides Updates on Payments Under Financing Transaction and Amended 2019 Note (GlobeNewswire) -6.33%
Mar-30-23 04:30AM	Uxin Reschedules the Release of Its Financial Results for the Third Quarter of Fiscal Year 2023 (GlobeNewswire)
Mar-24-23 06:00AM	Uxin to Report Third Quarter Fiscal Year 2023 Financial Results on March 31, 2023 (GlobeNewswire)
Feb-23-23 04:07PM	12 High Growth Penny Stocks that are Profitable (Insider Monkey)
Jan-10-23 07:47AM	Uxin Limited (NASDAQ:UXIN) Q2 2023 Earnings Call Transcript (Insider Monkey)
Jan-05-23 08:28AM	UXIN: Chinese used car retailer reports 2nd fiscal quarter results which were broadly in line with expectations. Profitable growth is expected to occur in calendar year 2023. (Zacks Small Cap Research) +11.35%
Jan-01-23 07:03AM	Uxin Second Quarter 2023 Earnings: CN¥2.58 loss per share (vs CN¥43.65 loss in 2Q 2022) (Simply Wall St.)
Dec-30-22 06:47AM	Uxin Clocks ~79% Revenue Growth In Q2 (Benzinga) -8.86%
04:48AM	Uxin Reports Unaudited Second Quarter of Fiscal Year 2023 Financial Results (GlobeNewswire)
Dec-23-22 08:00AM	Uxin to Report Second Quarter Fiscal Year 2023 Financial Results on December 30, 2022 (GlobeNewswire)
Dec-22-22 08:00AM	Uxin Completes Major Upgrade on its Xian Inspection and Reconditioning Center (GlobeNewswire)

Uxin Ltd. engages in the operation of an online used car transaction services platform. The company was founded by Dai Kun on August 11, 2011 and is headquartered in Beijing, China.

FounderMr. Kun Dai

PresidentMr. Wenbing A Jing

Chief Financial OfficerMr. Feng Lin

Chief Operating OfficerMr. Zhitian Zhang

Head of Corporate FinanceHenry Tsai

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Dai Kun	Chief Executive Officer	Oct 06 '26	Buy	1.24	7,023	8,697	46,261	Oct 07 08:00 AM
Dai Kun	Chief Executive Officer	Oct 05 '26	Buy	1.27	8,683	11,016	39,238	Oct 06 09:15 AM
Dai Kun	Chief Executive Officer	Oct 02 '26	Buy	1.29	5,672	7,323	30,555	Oct 05 09:00 AM
Dai Kun	Chief Executive Officer	Oct 01 '26	Buy	1.42	9,000	12,794	24,883	Oct 02 07:56 AM
Dai Kun	Chief Executive Officer	Sep 30 '26	Buy	1.34	7,443	9,945	15,883	Oct 01 07:55 AM
Dai Kun	Chief Executive Officer	Sep 29 '26	Buy	1.26	8,440	10,611	8,440	Sep 30 09:31 AM
Li Bin (William)	Director	Sep 23 '26	Buy	0.01	104,931,794	996,852	13,115,578,738	Sep 24 08:29 AM

AGMB

AgomAb Therapeutics NV ADR

UXIN

Uxin Ltd ADR

AGMB

AgomAb Therapeutics NV ADR

UXIN

Uxin Ltd ADR

Upgrade your Finviz experience